| scholarly article | Q13442814 |
| P356 | DOI | 10.4061/2011/230671 |
| P953 | full work available online at | http://downloads.hindawi.com/journals/jos/2011/230671.pdf |
| http://downloads.hindawi.com/journals/jos/2011/230671.xml | ||
| https://downloads.hindawi.com/journals/jos/2011/230671.pdf | ||
| https://europepmc.org/articles/PMC3135090 | ||
| https://europepmc.org/articles/PMC3135090?pdf=render | ||
| P932 | PMC publication ID | 3135090 |
| P698 | PubMed publication ID | 21772971 |
| P5875 | ResearchGate publication ID | 51505803 |
| P2093 | author name string | Luigi Gennari | |
| Ranuccio Nuti | |||
| Daniela Merlotti | |||
| Konstantinos Stolakis | |||
| P2860 | cites work | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| Polymorphism of the Aromatase Gene in Postmenopausal Italian Women: Distribution and Correlation with Bone Mass and Fracture Risk1 | Q56004938 | ||
| Association of Hypogonadism and Estradiol Levels with Bone Mineral Density in Elderly Men from the Framingham Study | Q57244903 | ||
| Conversion of Androgens to Estrogens in Cirrhosis of the Liver1 | Q66934687 | ||
| Changes in plasma lipoproteins during various androgen suppression therapies in men with prostatic carcinoma: effects of orchiectomy, estrogen, and combination treatment with luteinizing hormone-releasing hormone agonist and flutamide | Q68125383 | ||
| Androstenedione metabolism in cultured human osteoblast-like cells | Q68185095 | ||
| Aromatase activity in human osteoblast-like osteosarcoma cell | Q70586355 | ||
| Estrogen and androgen dynamics in liver disease | Q70767191 | ||
| Aromatase expression in a feminizing adrenocortical tumor | Q71477134 | ||
| The endocrinology of testicular germinal cell tumours | Q72640363 | ||
| Aromatase deficiency caused by a novel P450arom gene mutation: impact of absent estrogen production on serum gonadotropin concentration in a boy | Q73194226 | ||
| Genetic variants of CYP19 (aromatase) and breast cancer risk | Q73540247 | ||
| Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads | Q73621926 | ||
| Estrogen replacement therapy in a man with congenital aromatase deficiency: effects of different doses of transdermal estradiol on bone mineral density and hormonal parameters | Q73866977 | ||
| A highly complex organization of the regulatory region of the human CYP19 (aromatase) gene revealed by the Human Genome Project | Q74619026 | ||
| Increased Bone Mass as a Result of Estrogen Therapy in a Man with Aromatase Deficiency | Q77153494 | ||
| Androgens and bone | Q79811504 | ||
| Skeletal effects of long-term estrogen and testosterone replacement treatment in a man with congenital aromatase deficiency: evidences of a priming effect of estrogen for sex steroids action on bone | Q80073759 | ||
| A novel compound heterozygous mutation of the aromatase gene in an adult man: reinforced evidence on the relationship between congenital oestrogen deficiency, adiposity and the metabolic syndrome | Q80426117 | ||
| Aromatase expression in osteoarthritic and osteoporotic bone | Q81361016 | ||
| Effects of aromatase inhibition in hypogonadal older men: a randomized, double-blind, placebo-controlled trial | Q81616161 | ||
| Estrogen and fracture risk in men | Q81989979 | ||
| Journal of Bone and Mineral Research | Q15750941 | ||
| Variants in estrogen-biosynthesis genes CYP17 and CYP19 and breast cancer risk: a family-based genetic association study | Q24796616 | ||
| History of aromatase: saga of an important biological mediator and therapeutic target | Q28242399 | ||
| Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man | Q28248505 | ||
| Dual activation of PPARα and PPARγ by mono-(2-ethylhexyl) phthalate in rat ovarian granulosa cells | Q28566754 | ||
| Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene | Q28588388 | ||
| Divergent effects of short term glucocorticoid excess on the gonadotropic and somatotropic axes in normal men | Q30442833 | ||
| Pubertal bone growth in the femoral neck is predominantly characterized by increased bone size and not by increased bone density--a 4-year longitudinal study | Q31141283 | ||
| Insulin sensitizer, troglitazone, directly inhibits aromatase activity in human ovarian granulosa cells. | Q31378291 | ||
| A loss of aggressive behaviour and its reinstatement by oestrogen in mice lacking the aromatase gene (Cyp19). | Q31971405 | ||
| Multiple Splicing Events Involved in Regulation of Human Aromatase Expression by a Novel Promoter, I.6* | Q32075010 | ||
| Bioavailable estradiol may be an important determinant of osteoporosis in men: the MINOS study | Q32087313 | ||
| CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium | Q33616702 | ||
| Do intracrine mechanisms regulate aromatase expression? | Q33695092 | ||
| The gene for aromatase, a rate-limiting enzyme for local estrogen biosynthesis, is a downstream target gene of Runx2 in skeletal tissues | Q33826530 | ||
| Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes | Q33829174 | ||
| Expression of aromatase, androgen and estrogen receptors in peripheral target tissues in diabetes. | Q33937154 | ||
| Update on Estrogens and the Skeleton | Q34031994 | ||
| Role of aromatase in sex steroid action | Q34050360 | ||
| Minireview: aromatase and the regulation of estrogen biosynthesis--some new perspectives | Q34095564 | ||
| Pathogenesis of bone fragility in women and men. | Q34131375 | ||
| Sex steroids and the construction and conservation of the adult skeleton | Q34131889 | ||
| Aromatase deficiency and estrogen resistance: from molecular genetics to clinic. | Q34220644 | ||
| Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen | Q50877209 | ||
| Aromatase in Human Bone Tissue | Q50936551 | ||
| Androgen supplementation in eugonadal men with osteoporosis: effects of six months' treatment on markers of bone formation and resorption | Q50966362 | ||
| 1,25-Dihydroxyvitamin D3 enhances the enzymatic activity and expression of the messenger ribonucleic acid for aromatase cytochrome P450 synergistically with dexamethasone depending on the vitamin D receptor level in cultured human osteoblasts | Q51035392 | ||
| Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBPbeta in endometriosis is associated with overexpression of aromatase | Q52546013 | ||
| Serum oestradiol and oestrogen-receptor gene polymorphism are associated with bone mineral density independently of serum testosterone in normal males | Q54099094 | ||
| Effects of Raloxifene, a Selective Estrogen Receptor Modulator, on Bone Turnover Markers and Serum Sex Steroid and Lipid Levels in Elderly Men | Q43791669 | ||
| Dehydroepiandrosterone (DHEA) as a possible source for estrogen formation in bone cells: correlation between bone mineral density and serum DHEA-sulfate concentration in postmenopausal women, and the presence of aromatase to be enhanced by 1,25-dihy | Q44014868 | ||
| Gastric parietal cells: potent endocrine role in secreting estrogen as a possible regulator of gastro-hepatic axis | Q44072091 | ||
| Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene | Q44238603 | ||
| Differential effects of androgens and estrogens on bone turnover in normal men. | Q44273273 | ||
| Fenofibrate, a ligand for PPARalpha, inhibits aromatase cytochrome P450 expression in the ovary of mouse | Q44308529 | ||
| Aerobic exercise and bone mineral density in middle-aged finnish men: a controlled randomized trial with reference to androgen receptor, aromatase, and estrogen receptor α gene polymorphisms | Q44399756 | ||
| Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men. | Q44645555 | ||
| Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment | Q44722992 | ||
| Polymorphisms in the P450 c17 (17-hydroxylase/17,20-Lyase) and P450 c19 (aromatase) genes: association with serum sex steroid concentrations and bone mineral density in postmenopausal women | Q44723109 | ||
| Genetic variation in sex hormone genes influences heel ultrasound parameters in middle-aged and elderly men: results from the European Male Aging Study (EMAS). | Q44860434 | ||
| A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism. | Q44924325 | ||
| Estrogens are essential for male pubertal periosteal bone expansion | Q45173609 | ||
| Endogenous Sex Steroids and Bone Mineral Density in Older Women and Men: The Rancho Bernardo Study | Q46270750 | ||
| Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men. | Q46459550 | ||
| Prevalence of Helicobacter pylori infection in male patients with osteoporosis and controls | Q46500936 | ||
| A novel mutation in the human aromatase gene: insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment | Q46509716 | ||
| Older men with low serum estradiol and high serum SHBG have an increased risk of fractures | Q46563340 | ||
| Polymorphisms in the aromatase gene predict areal BMD as a result of affected cortical bone size: the GOOD study | Q46898256 | ||
| A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk | Q46920362 | ||
| Aromatase expression of human osteoblast-like cells | Q47683998 | ||
| Association of the aromatase gene alleles with BMD: epidemiological and functional evidence. | Q47871662 | ||
| Human gene mutations. Gene symbol: CYP19. Disease: Aromatase deficiency | Q47876422 | ||
| Disruption of sexual behavior in male aromatase-deficient mice lacking exons 1 and 2 of the cyp19 gene | Q48344072 | ||
| The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters | Q34277412 | ||
| Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens | Q34368450 | ||
| Clinical review 137: Sexual dimorphism in skeletal size, density, and strength | Q34401015 | ||
| Effect of Testosterone and Estradiol in a Man with Aromatase Deficiency | Q34431437 | ||
| Clinical review 144: Estrogen and the male skeleton | Q34587203 | ||
| CpG dinucleotide methylation of the CYP19 I.3/II promoter modulates cAMP-stimulated aromatase activity. | Q34737250 | ||
| Glyphosate-based herbicides are toxic and endocrine disruptors in human cell lines | Q34987770 | ||
| Inhibition of human aromatase by myosmine | Q34992239 | ||
| Aromatase deficiency in men: a clinical perspective | Q34999472 | ||
| The importance of oestrogens in males. | Q35109134 | ||
| Aromatase in bone: roles of Vitamin D3 and androgens | Q35586812 | ||
| Aromatase activity and bone homeostasis in men. | Q35973043 | ||
| Human aromatase: cDNA cloning, Southern blot analysis, and assignment of the gene to chromosome 15. | Q36453370 | ||
| CCAAT/enhancer binding protein beta regulates aromatase expression via multiple and novel cis-regulatory sequences in uterine leiomyoma | Q36494372 | ||
| Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk | Q36618233 | ||
| Polymorphisms in the CYP19 gene that influence bone mineral density | Q36772834 | ||
| Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium | Q37157438 | ||
| Genetic variations in sex steroid-related genes as predictors of serum estrogen levels in men. | Q37189990 | ||
| The alternative noncoding exons 1 of aromatase (Cyp19) gene modulate gene expression in a posttranscriptional manner | Q37244690 | ||
| Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men | Q37272054 | ||
| Metformin inhibits aromatase via an extracellular signal-regulated kinase-mediated pathway | Q37359363 | ||
| Sex steroids and bone mass in older men. Positive associations with serum estrogens and negative associations with androgens | Q37372883 | ||
| Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels. | Q37482736 | ||
| Estrogens as regulators of bone health in men. | Q37520591 | ||
| Genetic and clinical spectrum of aromatase deficiency in infancy, childhood and adolescence | Q37618499 | ||
| Association between CYP19 polymorphisms and breast cancer risk: results from 10,592 cases and 11,720 controls. | Q37669267 | ||
| PPARγ in bone homeostasis | Q37791645 | ||
| Aromatase in bone cell: association with osteoporosis in postmenopausal women. | Q40455019 | ||
| Aromatase expression in the human fetal osteoblastic cell line SV-HFO. | Q40568758 | ||
| Regulation of aromatase by nuclear receptors | Q40750401 | ||
| Sex hormone binding globulin binding capacity, testosterone, 5alpha-dihydrotestosterone, oestradiol and prolactin in plasma of patients with prostatic carcinoma under various types of hormonal treatment | Q40777914 | ||
| Combined treatment with specific ligands for PPARgamma:RXR nuclear receptor system markedly inhibits the expression of cytochrome P450arom in human granulosa cancer cells | Q40789660 | ||
| Hormonal and biochemical parameters in the determination of osteoporosis in elderly men. | Q40793714 | ||
| Endocrine disorders associated with inappropriately high aromatase expression | Q41640151 | ||
| Low levels of estradiol are associated with vertebral fractures in older men, but not women: the Rancho Bernardo Study | Q41714023 | ||
| Bioavailable estradiol and an aromatase gene polymorphism are determinants of bone mineral density changes in men over 70 years of age. | Q42169651 | ||
| Physiological Changes in Dehydroepiandrosterone Are Not Reflected by Serum Levels of Active Androgens and Estrogens But of Their Metabolites: Intracrinology | Q42548263 | ||
| Diabetes alters aromatase enzyme levels in gonadal tissues of rats | Q43080863 | ||
| Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase | Q43124196 | ||
| The effect of aromatase inhibition on sex steroids, gonadotropins, and markers of bone turnover in older men. | Q43633936 | ||
| Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. | Q43705600 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 230671 | |
| P577 | publication date | 2011-06-24 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Journal of Osteoporosis | Q26841978 |
| P1476 | title | Aromatase Activity and Bone Loss in Men | |
| P478 | volume | 2011 |
| Q34395346 | Androgens and estrogens in skeletal sexual dimorphism. |
| Q51743813 | Evaluation of Meibomian Gland Dysfunction in Polycystic Ovary Syndrome and Obesity |
| Q54965039 | Impact of sarcopenia in borderline resectable and locally advanced pancreatic cancer patients receiving stereotactic body radiation therapy. |
| Q38077109 | Osteoporosis in men: recent progress |
| Q35132577 | The role of oxidative stress in menopause |
| Q90153213 | Transcriptome-wide piRNA profiling in human brains for aging genetic factors |
Search more.